Fairvalue-Calculator Fairvalue-Calculator
EN DE

Inspire Medical Systems, Inc (INSP) Fair Value & Analysis

Healthcare · US · Market cap $1.2B

Price$43.20
Fair Value$85.80
Upside+98.6%
Quality95/100
Evidence: High Range $40.55 – $107.25

Fair value as of: Jun 25, 2026

Analysis

Inspire Medical Systems, Inc (INSP) currently trades at $43.20, while our model-based Fair Value estimate is $85.80 — implying the stock looks roughly 98.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Inspire Medical Systems, Inc (INSP) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $85.80 versus a price of $43.20 — about +99% (undervalued). Model-based estimate, not financial advice.
What is the fair value of INSP?
Our 21-model fair value for Inspire Medical Systems, Inc is $85.80 (as of Jun 25, 2026), built from audited fundamentals. The current price is $43.20.
What is the quality score of INSP?
Inspire Medical Systems, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.